ArticleThe Journal of international medical research2021
Primary cardiac angiosarcoma: a case report.
Article in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 36 citations in OpenAlex.
- Presumed Primary Cardiac Angiosarcoma With Atrioventricular Groove Rupture and Right Coronary Artery Compromise: A Case Report and Literature Review.Clinical case reports · 2026Article
- Primary cardiac angiosarcoma with isolated superior vena cava syndrome: a case report.Journal of medical case reports · 2026Article
- Cardiac angiosarcoma in acute pericardial tamponade with hemoptysis: A case report.The Journal of international medical research · 2025Article
- Case report: Diversity of imaging in cardiac angiosarcoma: two cases with disparate enhancement and metabolic manifestations.Frontiers in oncology · 2025Article
- Article
- Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report.Journal of cardiothoracic surgery · 2024Article
- A bleeding heart: case report and review of pericardial angiosarcoma.Autopsy & case reports · 2024Article
- Primary cardiac angiosarcoma presenting with haemoptysis.BMJ case reports · 2023Article
- Primary Cardiac Angiosarcoma in a Patient with Syncope: A Case Report.Chonnam medical journal · 2023Article
- Age and treatment disparities in survival of primary malignant cardiac tumors: an analysis of over 40 years and 500 patients.Journal of thoracic disease · 2023Article
- Article
- Primary Cardiac Angiosarcoma: A Review.Cureus · 2023Review
- Postoperative radiotherapy for high-grade primary cardiac spindle cell sarcoma: a rare entity.BMJ case reports · 2023Article
- Treatment of an unresectable cardiac angiosarcoma using paclitaxel and image guided radiotherapy: Case report and literature review.Clinical and translational radiation oncology · 2023Article
- Article
- A case of primer angiosarcoma ın a young woman: lessons from multi-modality ımaging.The international journal of cardiovascular imaging · 2022Article
- Case report: Unique FLT4 variants associated with differential response to anlotinib in angiosarcoma.Frontiers in oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cardiac angiosarcoma is relatively rare, and most cases involve metastasis at the time of diagnosis. The median survival time is 14 months for patients who can be treated surgically, versus 3.8 ± 2.5 months for patients with metastasis who could not undergo surgery. Radical surgical resection, radiotherapy, chemotherapy, and targeted therapy are the main treatments, but prognosis remains poor because of rapid progression and high recurrence and metastasis rates. At present, there is no unified standard treatment, and selecting the correct treatment plan and improving patient survival and quality of life remain challenging. We have reported the case of a 45-year-old woman with a primary heart tumor that infiltrated the right atrial wall and pericardium. Angiosarcoma was verified histologically. After palliative resection of the primary tumor followed by concurrent chemoradiotherapy and targeted therapy, the patient exhibited overall survival of 23 months, highlighting the potential utility of this treatment strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.